Raymond James Downgrades Alignment Healthcare to Outperform, Lowers Price Target to $19

Benzinga Newsdesk www.benzinga.com Negative 92.4%

Neg 92.4% Neu 0% Pos 0%

Raymond James analyst John Ransom downgrades Alignment Healthcare (NASDAQ:ALHC) from Strong Buy to Outperform and lowers the price target from $22 to $19.